Prognosis and survival with extranodal Hodgkin's disease.
D000328:Adult; D002330:Carmustine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D010166:Palliative Care; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D014748:Vinca Alkaloids; D002699:Chlorambucil; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D002330:Carmustine; D011241:Prednisone